29 min
 
Handout: 
Bitbit.ly/4a08Vf3
 
During this presentation, Matt Lester, RPh, MBA, BCSCP, will discuss LDN in oncology. After this presentation the viewer should be able to:
 
-Identify contributors to inflammation
 
-Understand link between inflammation and cancer
 
-Explain some of the relationships between the immune system and cancer
 
-Illustrate some of the uses of low-dose natrexone (LDN) in cancer
 
-Detail relationship between opioid growth factor, LDN and cancer
 
-Discuss LDN dosing protocols